Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome

Pharmacotherapy

Volumn 31, Issue 5, 2011, Pages 503-509

  Tillman, Emma M ^a,b,c   Crill, Catherine M ^a,b   Black, Dennis D ^a,b,c   Hak, Emily B ^a,b   Lazar, Linda F ^a   Christensen, Michael L ^a,b,c   Huang, Eunice Y ^a   Helms, Richard A ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b State of Tennessee Center of Excellence in Pediatric Pharmacokinetics and Therapeutics   (United States)

^c LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Enteral fish oil; Infants; Nutrition; Parenteral nutrition associated liver disease; PNALD; SBS; Short bowel syndrome

Indexed keywords

BILIRUBIN; FISH OIL; URSODEOXYCHOLIC ACID;

ANASTOMOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE STUDY; CLINICAL ARTICLE; DRUG EFFICACY; ENTERIC FEEDING; FEMALE; HUMAN; INFANT; JEJUNOSTOMY; LIVER DISEASE; MALE; NASOGASTRIC TUBE; NECROTIZING ENTEROCOLITIS; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; RETROSPECTIVE STUDY; SHORT BOWEL SYNDROME; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; STOMACH TUBE; SUPPLEMENTATION; TREATMENT DURATION;

BILIRUBIN; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; FEMALE; FISH OILS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINAL DISEASES; LIVER DISEASES; MALE; PARENTERAL NUTRITION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SHORT BOWEL SYNDROME;

EID: 79955585776     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.5.503     Document Type: Article

References (23)

1. Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 1979;64:342-7. (Pubitemid 9231684)
2. Whitington PF. Cholestasis associated with total parenteral nutrition in infants. Hepatology 1985;5:693-6. (Pubitemid 15029745)
3. Sinatra FR. Cholestasis in infancy and childhood. Curr Probl Pediatr 1982;12:1-54.
4. Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr 1986;5:9-22. (Pubitemid 17006360)
5. Gura KM, Parsons SK, Bechard LJ, et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy-allergic patient receiving parenteral nutrition. Clin Nutr 2005;24:839-47. (Pubitemid 41403641)
6. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short-bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118:e197-201.
7. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:e678-86.
8. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009;250:395-402.
9. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short-bowel syndrome. J Pediatr Gastroenterol Nutr 2009;48:209-15.
10. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish oil-based lipid. Clin Nutr 2009;28:209-12.
11. Calhoun AW, Sullivan JE. Omegaven for the treatment of parenteral nutrition-associated liver disease: a case study. J Ky Med Assoc 2009;107:55-7.
12. Chung PH, Wong KK, Wong RM, Tsoi NS, Chan KL, Tam PK. Clinical experience in managing pediatric patients with ultrashort- bowel syndrome using omega-3 fatty acid. Eur J Pediatr Surg 2010;20:139-42.
13. Ekema G, Falchetti D, Boroni G, et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short-bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg 2008;43:1191-5. (Pubitemid 351814874)
14. Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short-bowel syndrome. Nutr Clin Pract 2010;25:199-204. (Erratum in Nutr Clin Pract 2010;25:315.)
15. Reliant Pharmaceuticals. Lovaza (omega-3-acid ethyl esters) package insert. Durham, NC; 2007.
16. Nature Made. Fish oil 1000 mg. Available from www.nature made.com. Accessed May 15, 2008.
17. Nature's Bounty. Fish oil 1000 mg. Available from www.natures bounty.com. Accessed May 15, 2008.
18. Fresenius Kabi AG. Omegaven (fish oil-based intravenous fat emulsion) package insert. Bad Homburg v.d.h., Germany; 2001.
19. Horslen SP, Sudan DL, Iyer KR, et al. Isolated liver transplantation in infants with end-stage liver disease associated with short-bowel syndrome. Ann Surg 2002;235:435-9. (Pubitemid 34183895)
20. Javid PJ, Collier S, Richardson D, et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg 2005;40:1015-18. (Pubitemid 40840821)
21. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007;99:C35-43.
22. Harris WS. Expert opinion: omega-3 fatty acids and bleeding: cause for concern? Am J Cardiol 2007;99:C44-6.
23. Alwayn IP, Gura K, Nose V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005;57:445-52. (Pubitemid 40293615)